This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit | Clinical Laboratory Marketplace    

Home   About   Scholarships   Meetings   Publications   Resources   May. 22, 2012

 


Study unpicks gene changes behind breast cancer
Reuters via Medscape    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists have mapped the complete genetic codes of 21 breast cancers and created a catalog of the mutations that accumulate in breast cells, raising hopes that the disease may be able to be spotted earlier and treated more effectively in future. The research, the first of its kind, untangles the genetic history of how cancer evolves, allowing scientists to identify mutational patterns that fuel the growth of breast tumors and start to work out the processes behind them. More

Creative Laboratory Products

Based in Indianapolis, we create our products in FDA licensed laboratories to ensure the highest quality possible. We provide fast solutions for customer's individual lipid additives. Click here to learn more.


Are you choosing tests wisely? A challenge from the ABIM Foundation
Medscape Internal Medicine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Choosing Wisely, an initiative of the American Board of Internal Medicine (ABIM) Foundation, comprises evidence-based recommendations from nine specialty organizations on questionable tests and procedures. The goal is to use these recommendations as the basis for discussions between clinicians and patients. Medscape interviewed Christine Cassel, M.D., president of ABIM, on the history of this initiative and its importance to health professionals and their patients. More

Many rare mutations may underpin diseases
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The task of finding the genetic roots of common disease seems much harder, dimming the promise of personal genomics and the chances of quick medical payoffs from the human genome project, given new data about the human genome in two reports published online in the journal Science. More



NIH-led study finds genetic test results do not trigger increased use of health services
National Human Genome Research Institute    Share    Share on FacebookTwitterShare on LinkedinE-mail article
People have increasing opportunities to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminish test recipients' demand for potentially costly follow-up health services, according to a study performed by researchers at the National Institutes of Health and colleagues at other institutions. More

Fast growth in real and 'virtual' biobanks may be revenue opportunity for clinical pathology laboratories
DARK Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VisionGain estimates that biobanking is now a $7.9 billion industry. That's a revenue number that should interest pathologists and clinical laboratory managers, since their organizations access large volumes of patient specimens every year. As one source of human specimens, both clinical laboratories and anatomic pathology groups have an opportunity to participate in biobanking activities. At this stage in the market, however, few medical laboratories formally participate in biobanking activities. Experts believe that is likely to change. More


CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

1-800-379-0957. diaginfo@grifols.com
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.


Bacterial identification — Where mass spectrometry meets microbiology
Clinical Laboratory News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A guiding principle of clinical laboratories is to provide patient test results as quickly as possible while maintaining accuracy and quality. Therefore, advancements in analytical technology that not only improve accuracy and quality, but also decrease the length of time from sample collection to results are highly desirable. In the clinical microbiology laboratory where many traditional culture-based methods take days to yield results, providing diagnostic information in a matter of hours using mass spectrometry and molecular techniques holds the potential for vast improvements in patient care. More

Antigen test designed for point-of-care detection
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A novel antigen detection test shows efficacy in rapidly identifying a variety of respiratory viruses at the point of care in a pediatric setting, according to research presented at the European Society for Paediatric Infectious Diseases 30th Annual Meeting in Greece. The automated, multianalyte system, called MariPOC (ArcDia, Turku, Finland), is capable of detecting 8 respiratory viruses — respiratory syncytial virus; influenza A and B viruses; adenovirus; parainfluenza type 1, 2, and 3 viruses; and human metapneumovirus — from a single nasopharyngeal swab specimen. More



CDC to baby boomers: Get tested for hepatitis C
The Associated Press via ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For the first time, the government is proposing that all baby boomers get tested for hepatitis C. Anyone born from 1945 to 1965 should get a one-time blood test to see if they have the liver-destroying virus, the Centers for Disease Control and Prevention said in draft recommendations. More

Military vets and the lab: An ideal match
Advance for Administrators of the Laboratory    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For those men and women that fight for our country in the military, there may come a time after serving overseas to reenter the civilian workforce and transition to a different career. For some, a career in the clinical laboratory is an attractive option. More


We've teamed up to save you even more on car insurance.

Find out if you're eligible for exclusive GEICO savings by starting a rate quote now – just make sure you select your group affiliation when asked.
MORE
JoinYour Peers

Many employers now require certification because they know that individuals who are certified are committed to their profession and to quality patient care. Learn how we can help!

www.americanmedtech.org


Blood biomarkers could personalize treatment in rectal cancer
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Three blood biomarkers are strong predictors of response to chemoradiation therapy for rectal cancer and could be used with other predictors to tailor treatment. More



Blood test can predict breast cancer risk
LabMedica International    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A blood test that spots changes in a specific gene could reveal a woman's risk for breast cancer years before the disease has a chance to develop. Women with the highest level of methylation on one area gene were more likely to develop cancer than those with the lowest level of methylation because high levels of methylation signal high levels of DNA flaws. More

In clinical trials, breath test for lung cancer shows promise
for earlier detection

Dark Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Here's a medical laboratory test for diagnosing cancer that has the potential to score two runs with one swing of the bat. First, researchers have completed the first clinical trial of a noninvasive cancer test that utilizes a breath specimen. Second, the subject of this clinical trial was lung cancer — a type of cancer that would benefit from a pathology test that can detect the disease much earlier. This would increase the survival rates for lung cancer, which currently has a five-year mortality rate of 90 percent. More

Expand your career as a Clinical Lab Scientist at UCSF Medical Center.

Opportunities available in San Francisco, CA in various areas - Chemistry, Hematology, Blood Bank, Immunology, Microbiology, Molecular Diagnostics, Bone Marrow Transplant, and Cytogenetics. Apply online or contact Cheryl Hardin at Cheryl.Hardin@ucsfmedctr.org for more information. EOE.


Technology powered by viruses? Scientists move closer
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Viruses might eventually be able to power the very phone, computer or tablet you're reading this article on. Scientists at the U.S. Department of Energy's Berkeley Lab have found a way to generate power using human viruses. With a harmless specially engineered M13 virus, the group has been able to power a small display. The viruses can covert mechanical force into electricity. More



Human embryonic stem cells can be used to grow bone tissue grafts
News-Medical.Net    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study shows human embryonic stem cells can be used to grow bone tissue grafts for use in research and potential therapeutic application. The study is the first example of using bone cell progenitors derived from human embryonic stem cells to grow compact bone tissue in quantities large enough to repair centimeter-sized defects. More
 


ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Yvette Craig, Senior Content Editor, 469.420.2641   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

May 21, 2012
May 15, 2012
May 8, 2012
May 1, 2012






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063